Top 20 Companies in Global Amyloid Peptides Market: Global Share, Market Size, Revenue Report (2024–2035)
RELEASE DATE: Mar 2026 Author: Spherical InsightsRequest Free Sample Speak to Analyst
Introduction
The global amyloid peptides market refers to the industry which produces and uses amyloid peptides. These peptides consist of short amino acid chains which develop into insoluble fibrillar protein deposits that cause various protein misfolding disorders and neurodegenerative diseases. Researchers synthesize these peptides through the combination of high-purity amino acids and peptide synthesis reagents and solvents and advanced laboratory materials which are essential for biochemical and pharmaceutical research. Amyloid peptides serve multiple purposes including drug discovery and disease mechanism research and biomarker identification and diagnostic studies especially in protein aggregation studies and neurodegenerative research. The market is experiencing growing demand because of increased interest in peptide-based therapeutics together with improvements in peptide synthesis methods and the growth of biotechnology research activities. The emergence of new treatment methods and the progress of precision medicine research and the partnership between educational institutions and biotechnology firms are creating new opportunities. The worldwide amyloid peptides market experiences growth from public funding support for neuroscience research and existing regulatory frameworks which encourage biomedical research and increased funding for life sciences research.
Navigate Future Markets with Confidence: Insights from Spherical Insights LLP
The insights presented in this blog are derived from comprehensive market research conducted by Spherical Insights LLP, a trusted advisory partner to leading global enterprises. Backed by in-depth data analysis, expert forecasting, and industry-specific intelligence, our reports empower decision-makers to identify strategic growth opportunities in fast-evolving sectors. Clients seeking detailed market segmentation, competitive landscapes, regional outlooks, and future investment trends will find immense value in the full report. By leveraging our research, businesses can make informed decisions, gain a competitive edge, and stay ahead in the transition toward sustainable and profitable solutions.
Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the Amyloid Peptides Market.
Global Amyloid Peptides Market Size, Share, By Product Type (Synthetic Amyloid Peptides, Natural Amyloid Peptides), By Application (Research, Drug Development, Diagnostics, Therapeutics), By End User (Pharmaceutical Companies, Research Institutes, Diagnostic Laboratories, Hospitals), Analysis and Forecast 2025 - 2035
Amyloid Peptides Market Size & Statistics
- The Market Size for Amyloid Peptides Was Estimated to be worth USD 1.4 Billion in 2024.
- The Market is going to Expand at a CAGR of 9.76% between 2025 and 2035.
- The Amyloid Peptides Market Size is anticipated to reach USD 3.9Billion by 2035.
- North America is expected to generate the highest demand during the forecast period in the Amyloid Peptides Market
- Asia Pacific is expected to grow the fastest during the forecast period in the Amyloid Peptides Market.
Regional growth and demand
Asia Pacific is expected to grow the fastest during the forecast period in the Amyloid Peptides market. Asia Pacific is expected to grow fastest due to expanding biotechnology research, rising healthcare investments, increasing prevalence of neurodegenerative diseases, growing pharmaceutical manufacturing, and strong government support for life science research.
North America is expected to generate the highest demand during the forecast period in the Amyloid Peptides market. North America is expected to advanced biotechnology infrastructure, strong pharmaceutical research activities, high healthcare spending, increasing neurodegenerative disease research, and significant investment in peptide-based drug development.
Ready to lead the Amyloid Peptides Market ?
Discover the regional trends and growth factors shaping the industry. We’re here to assist with expert, personalized data.
Call +1 303 800 4326 or Send us a message for a personalized consultation.
Top 10 Trends in the Amyloid Peptides Market
- Rising neurodegenerative disease research
- Growth in amyloid-targeted therapeutics
- Use of amyloid peptides as biomarkers
- Advancements in peptide synthesis technologies
- AI integration in peptide drug discovery
- Increasing clinical trials
- Demand for high-purity synthetic peptides
- Focus on early disease detection
- Expanding biotech collaborations
- Growth in personalized medicine approaches
1.Rising Neurodegenerative Disease Research
Increasing global focus on understanding diseases related to protein aggregation is driving research activities. Scientists are extensively studying amyloid peptides to better understand disease mechanisms and develop targeted therapeutic strategies.
2.Growth in Amyloid-Targeted Therapeutics
Pharmaceutical companies are increasingly developing therapies that target amyloid peptide accumulation. These treatments aim to slow disease progression, creating strong demand for amyloid peptides in drug discovery and clinical research.
3.Use of Amyloid Peptides as Biomarkers
Amyloid peptides are widely used as biomarkers for early disease detection and diagnosis. Their role in identifying disease progression is expanding in clinical research and diagnostic development.
4.Advancements in Peptide Synthesis Technologies
Improved peptide synthesis techniques are enabling the production of high-purity and complex amyloid peptides. These technological advancements support large-scale research and pharmaceutical development activities.
5.AI Integration in Peptide Drug Discovery
Artificial intelligence is increasingly used to analyze peptide structures and predict therapeutic outcomes. This helps accelerate drug discovery processes and improves the efficiency of developing amyloid-targeted treatments.
Empower your strategic planning:
Stay informed with the latest industry insights and market trends to identify new opportunities and drive growth in the Amyloid Peptides market. To explore more in-depth trends, insights, and forecasts, please refer to our detailed report.
Top 20 Companies Leading the Amyloid Peptides Market
- Bachem Holding AG
- Thermo Fisher Scientific Inc.
- GenScript Biotech Corporation
- AnaSpec, Inc.
- Creative Peptides
- JPT Peptide Technologies GmbH
- PolyPeptide Group
- New England Peptide, Inc.
- BioLegend, Inc.
- rPeptide, LLC
- Merck KGaA
- Abcam plc
- Bio-Techne Corporation
- Eurogentec S.A.
- Peptide Institute, Inc.
- CPC Scientific Inc.
- LifeTein LLC
- Biomatik Corporation
- ProImmune Ltd.
- CSBio Company, Inc.
1.Bachem Holding AG
Headquarters: Bubendorf, Switzerland
Bachem Holding AG reported 2025 revenue of approximately USD 750 million. The company specializes in peptide synthesis and complex biochemical compounds used in pharmaceutical research. It supplies high-quality amyloid peptides for neuroscience research and drug development, supported by strong manufacturing capabilities and collaborations with global biotechnology and pharmaceutical companies.
2.Thermo Fisher Scientific Inc.
Headquarters: Waltham, Massachusetts, United States
Thermo Fisher Scientific Inc. generated about USD 44.9 billion in revenue in 2025. The company provides advanced laboratory technologies, peptide synthesis tools, and research reagents used in amyloid peptide studies. Its strong global distribution network and extensive research solutions support pharmaceutical, biotechnology, and academic research worldwide.
3.GenScript Biotech Corporation
Headquarters: Nanjing, China
GenScript Biotech Corporation recorded approximately USD 1.3 billion in 2025 revenue. The company offers peptide synthesis, gene synthesis, and biotechnology research services. It supplies customized amyloid peptides used in neuroscience research, biomarker discovery, and therapeutic development, supporting pharmaceutical companies and research institutions globally.
4.AnaSpec, Inc.
Headquarters: Fremont, California, United States
AnaSpec, Inc. generated estimated 2025 revenue of around USD 120 million. The company focuses on peptide synthesis, fluorescent reagents, and assay kits used in life science research. Its amyloid peptides are widely used in neurodegenerative disease studies, drug screening, and biochemical analysis.
5.Creative Peptides
Headquarters: Shirley, New York, United States
Creative Peptides reported estimated 2025 revenue of about USD 80 million. The company provides custom peptide synthesis and peptide-related research services. It supports amyloid peptide research through high-purity peptide production used in drug discovery, protein aggregation studies, and neurological disease research.
Are you ready to discover more about the Amyloid Peptides market?
The report provides an in-depth analysis of the leading companies operating in the Amyloid Peptides market. It includes a comparative assessment based on their product portfolios, business overviews, geographical footprint, strategic initiatives, market segment share, and SWOT analysis. Each company is profiled using a standardized format that includes:
Company Profile
- Bachem Holding AG
- Business Overview
- Company Snapshot
- Products Overview
- Company Market Share Analysis
- Company Coverage Portfolio
- Financial Analysis
- Recent Developments
- Merger and Acquisitions
- SWOT Analysis
- Thermo Fisher Scientific Inc.
- GenScript Biotech Corporation
- AnaSpec, Inc.
- Creative Peptides
- JPT Peptide Technologies GmbH
- PolyPeptide Group
- New England Peptide, Inc.
- BioLegend, Inc.
- Others.
Conclusion
The global amyloid peptides market is expected to witness significant growth over the forecast period due to increasing research on neurodegenerative diseases and the rising demand for peptide-based therapeutics. Advancements in peptide synthesis technologies, expanding biotechnology research, and growing investments from pharmaceutical companies are further supporting market expansion. The increasing use of amyloid peptides in drug discovery, diagnostics, and biomarker identification is also strengthening market demand. North America is anticipated to generate the highest demand due to its advanced research infrastructure and strong pharmaceutical industry, while Asia Pacific is projected to grow the fastest with increasing healthcare investments and biotechnology development.
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI. Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?